Self-assembling Releasable Thiocolchicine-Diphenylbutenylaniline Conjugates

Area of Science:

• Medicinal Chemistry
• Nanotechnology
• Drug Delivery

Background:

• Development of novel drug delivery systems is crucial for targeted therapy.
• Self-assembling conjugates offer potential for controlled drug release.
• Self-immolative linkers enable triggered drug release mechanisms.

Purpose of the Study:

• To design and synthesize novel self-assembling conjugates.
• To incorporate a self-immolative linker for lipase-induced controlled release.
• To evaluate the drug release, nanoparticle formation, and antiproliferative activity of the synthesized compounds.

Main Methods:

• Synthesis of self-assembling conjugates utilizing 4-(1,2-Diphenylbut-1-en-1-yl)aniline and amino-thiocolchicine.
• In vitro drug release studies using porcine pancreatic lipase and Celite-supported lipase.
• Nanoparticle characterization using dynamic light scattering, atomic force microscopy, and fluorescence microscopy.
• Assessment of antiproliferative activity on human cancer cell lines.

Main Results:

• Successful synthesis of self-assembling conjugates featuring a self-immolative linker.
• Demonstrated in vitro release of thiocolchicine derivative upon lipase cleavage.
• Confirmed formation of nanoparticles via DLS, AFM, and fluorescence microscopy.
• Exhibited significant antiproliferative activity against two human cancer cell lines.

Conclusions:

• The synthesized self-assembling conjugates effectively deliver drugs in a controlled manner.
• Lipase-cleavable self-immolative linkers are viable for triggered drug release.
• The developed nanoconjugates show promise as anticancer therapeutics.